A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

NCT01821274 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Irritation

Interventions

DRUG: Diltiazem Hydrochloride 2% Cream
DRUG: Vehicle Cream
DRUG: 0.1% solution o sodium lauryl sulfate (SLS)
DRUG: Saline 0.9%

Sponsor

Ventrus Biosciences, Inc